Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils.
The blood-brain barrier protects the brain against a variety of potentially toxic compounds. Barrier function results from tight junctions between brain capillary endothelial cells and high expression of active efflux transporters, including P-glycoprotein (Pgp), at the apical membrane of these cells. In addition to actively transporting drugs out of the cell, Pgp mediates lysosomal sequestration of chemotherapeutic drugs in cancer cells, thus contributing to drug resistance. Here, we describe that lysosomal sequestration of Pgp substrates, including doxorubicin, also occurs in human and porcine brain endothelial cells that form the blood-brain barrier. This is followed by shedding of drug-sequestering vesicular structures, which stay attached to the apical side of the plasma membrane and form aggregates ("barrier bodies") that ultimately undergo phagocytosis by neutrophils, thus constituting an as-yet-undescribed mechanism of drug disposal. These findings introduce a mechanism that might contribute to brain protection against potentially toxic xenobiotics, including therapeutically important chemotherapeutic drugs.
['Noack|Andreas|A|', 'Gericke|Birthe|B|', 'von Köckritz-Blickwede|Maren|M|', 'Menze|Arne|A|', 'Noack|Sandra|S|', 'Gerhauser|Ingo|I|', 'Osten|Felix|F|', 'Naim|Hassan Y|HY|', 'Löscher|Wolfgang|W|0000-0002-9648-8973']
D018435:ATP Binding Cassette Transporter, Subfamily B D000818:Animals D001812:Blood-Brain Barrier D002460:Cell Line D042783:Endothelial Cells D006801:Humans D008247:Lysosomes D009504:Neutrophils D010587:Phagocytosis D013552:Swine D015262:Xenobiotics
lysosomes neutrophils P-glycoprotein doxorubicin blood–brain barrier